Redmile Group, LLC Kymera Therapeutics, Inc. Transaction History

Redmile Group, LLC

$1.53 Billion
Q2 2024

A detailed history of Redmile Group, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 1,579,275 shares of KYMR stock, worth $71.7 Million. This represents 3.07% of its overall portfolio holdings.

Number of Shares

1,579,275

Previous 1,734,089 8.93%

Holding current value

$71.7 Million

Previous $69.7 Million 32.38%

% of portfolio

3.07%

Previous 2.75%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$29.85 - $39.42 $4.62 Million - $6.1 Million	-154,814 Reduced 8.93%	1,579,275 $47.1 Million
Q1 2024 May 15, 2024	SELL	$22.9 - $43.57 $2.06 Million - $3.92 Million	-89,867 Reduced 4.93%	1,734,089 $69.7 Million
Q4 2023 Feb 14, 2024	SELL	$10.97 - $26.84 $488,724 - $1.2 Million	-44,551 Reduced 2.38%	1,823,956 $46.4 Million
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $12.1 Million - $18.9 Million	-542,262 Reduced 22.49%	1,868,507 $43 Million
Q1 2023 May 15, 2023	SELL	$24.84 - $38.75 $6.53 Million - $10.2 Million	-263,068 Reduced 9.84%	2,410,769 $71.4 Million
Q4 2022 Feb 14, 2023	SELL	$19.57 - $30.92 $3.97 Million - $6.27 Million	-202,800 Reduced 7.05%	2,673,837 $66.7 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $5.64 Million - $9.24 Million	269,507 Added 10.34%	2,876,637 $62.6 Million
Q2 2022 Aug 15, 2022	SELL	$14.13 - $42.55 $111,627 - $336,145	-7,900 Reduced 0.3%	2,607,130 $51.3 Million
Q1 2022 May 16, 2022	BUY	$35.3 - $64.68 $963,689 - $1.77 Million	27,300 Added 1.05%	2,615,030 $111 Million
Q4 2021 Feb 14, 2022	SELL	$49.91 - $65.56 $10.3 Million - $13.5 Million	-205,978 Reduced 7.37%	2,587,730 $164 Million
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $12.5 Million - $17.5 Million	262,200 Added 10.36%	2,793,708 $164 Million
Q2 2021 Aug 16, 2021	SELL	$31.08 - $51.95 $2.23 Million - $3.72 Million	-71,631 Reduced 2.75%	2,531,508 $123 Million
Q1 2021 May 17, 2021	SELL	$35.64 - $85.46 $4.18 Million - $10 Million	-117,350 Reduced 4.31%	2,603,139 $101 Million
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $341,639 - $1.07 Million	-12,171 Reduced 0.45%	2,720,489 $169 Million
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $71.3 Million - $90.9 Million	2,732,660 New	2,732,660 $88.3 Million

Others Institutions Holding KYMR

# of Institutions

160

Shares Held

63.1M

Call Options Held

22.6K

Put Options Held

14.4K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.48B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.

Account

Redmile Group, LLC Kymera Therapeutics, Inc. Transaction History